-
Je něco špatně v tomto záznamu ?
Hearing loss in patients with Morquio A syndrome: A scoping review
L. Diaz-Ordoñez, PA. Duque-Cordoba, K. Silva-Cuero, JD. Gutierrez-Medina, W. Saldarriaga, L. Murgašová, M. Magner, E. Candelo, H. Pachajoa
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, scoping review
NLK
Directory of Open Access Journals
od 2014
PubMed Central
od 2013 do Před 2 týdny
Europe PubMed Central
od 2013
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2014-01-01
- MeSH
- lidé MeSH
- mukopolysacharidóza IV * komplikace epidemiologie diagnóza MeSH
- nedoslýchavost * epidemiologie diagnóza etiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- scoping review MeSH
BACKGROUND: Hearing impairment is a prevalent clinical feature in Morquio syndrome (mucopolysaccharidosis IVA or MPS IVA) patients, often presenting in diverse forms: conductive, sensorineural, or a combination known as mixed hearing loss. The mixed form entails a blend of both conductive and sensorineural elements, typically exhibiting a progressive trajectory. This scoping review aimed to comprehensively analyze available evidence pertaining to the pathophysiology, classification, epidemiology, and clinical management of hearing loss in individuals with MPS IVA. METHODS: Targeted literature was searched using MEDLINE, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Web of Science, the Cochrane Library, Trip Medical Database, Embase, ScienceDirect, and Google Scholar, with a second search cycle to identify gray literature. A systematic search strategy using Medical Subject Headings keywords was implemented: "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV" or "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV." The identified bibliography was uploaded to COVIDENCE platform for information management. Articles were screened by 3 independent reviewers following the eligibility criteria. RESULTS: Twenty-seven articles met the inclusion criteria, spanning information from 568 patients across 16 different countries. None of the studies had complete epidemiological information. Only 2 studies provided sufficient data to address the pathophysiology, while 3 addressed management and treatment. Hearing loss was reported in 210 of 568 patients. A total of 19.2% of patients reported recurrent ear infections. None of the studies reported vertigo, tinnitus, or dizziness in the patients. Pure-tone audiometry was the primary test used to diagnose and monitor auditory impairment in patients with Morquio syndrome. CONCLUSIONS: Five hundred sixty-eight patients with MPS IVA were identified, of whom 210 (37%) developed hearing loss, the most common of which was moderate. Despite the lack of information on the diagnosis and management of hearing loss in Morquio syndrome, this study found that approximately one-third of participants exhibited some form of auditory impairment, with the majority of these cases being sensorineural in nature.
Centro de Investigaciones Clínicas Fundación Valle del Lili Cali Colombia
Departamento de Ciencias Básicas Médicas Facultad de Salud Universidad Icesi Cali Colombia
Genetic Division Fundación Valle del Lili Cali Colombia
Hospital Universitario del Valle Cali Colombia
School of Basic Sciences Universidad del Valle Cali Colombia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010284
- 003
- CZ-PrNML
- 005
- 20250429135109.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MD.0000000000041128 $2 doi
- 035 __
- $a (PubMed)39792720
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Diaz-Ordoñez, Lorena $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia $u School of Basic Sciences, Universidad del Valle, Cali, Colombia $1 https://orcid.org/0000000231406332
- 245 10
- $a Hearing loss in patients with Morquio A syndrome: A scoping review / $c L. Diaz-Ordoñez, PA. Duque-Cordoba, K. Silva-Cuero, JD. Gutierrez-Medina, W. Saldarriaga, L. Murgašová, M. Magner, E. Candelo, H. Pachajoa
- 520 9_
- $a BACKGROUND: Hearing impairment is a prevalent clinical feature in Morquio syndrome (mucopolysaccharidosis IVA or MPS IVA) patients, often presenting in diverse forms: conductive, sensorineural, or a combination known as mixed hearing loss. The mixed form entails a blend of both conductive and sensorineural elements, typically exhibiting a progressive trajectory. This scoping review aimed to comprehensively analyze available evidence pertaining to the pathophysiology, classification, epidemiology, and clinical management of hearing loss in individuals with MPS IVA. METHODS: Targeted literature was searched using MEDLINE, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Web of Science, the Cochrane Library, Trip Medical Database, Embase, ScienceDirect, and Google Scholar, with a second search cycle to identify gray literature. A systematic search strategy using Medical Subject Headings keywords was implemented: "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV" or "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV." The identified bibliography was uploaded to COVIDENCE platform for information management. Articles were screened by 3 independent reviewers following the eligibility criteria. RESULTS: Twenty-seven articles met the inclusion criteria, spanning information from 568 patients across 16 different countries. None of the studies had complete epidemiological information. Only 2 studies provided sufficient data to address the pathophysiology, while 3 addressed management and treatment. Hearing loss was reported in 210 of 568 patients. A total of 19.2% of patients reported recurrent ear infections. None of the studies reported vertigo, tinnitus, or dizziness in the patients. Pure-tone audiometry was the primary test used to diagnose and monitor auditory impairment in patients with Morquio syndrome. CONCLUSIONS: Five hundred sixty-eight patients with MPS IVA were identified, of whom 210 (37%) developed hearing loss, the most common of which was moderate. Despite the lack of information on the diagnosis and management of hearing loss in Morquio syndrome, this study found that approximately one-third of participants exhibited some form of auditory impairment, with the majority of these cases being sensorineural in nature.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mukopolysacharidóza IV $x komplikace $x epidemiologie $x diagnóza $7 D009085
- 650 12
- $a nedoslýchavost $x epidemiologie $x diagnóza $x etiologie $7 D034381
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a scoping review $7 D000098583
- 700 1_
- $a Duque-Cordoba, Paola Andrea $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia
- 700 1_
- $a Silva-Cuero, Katherine $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia
- 700 1_
- $a Gutierrez-Medina, Juan David $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
- 700 1_
- $a Saldarriaga, Wilmar $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia $u Hospital Universitario del Valle, Cali, Colombia
- 700 1_
- $a Murgašová, Lenka $u Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of ENT, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Magner, Martin $u Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Pediatrics, Thomayer's University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Candelo, Estephania $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
- 700 1_
- $a Pachajoa, Harry $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia $u Genetic Division, Fundación Valle del Lili, Cali, Colombia
- 773 0_
- $w MED00012436 $t Medicine $x 1536-5964 $g Roč. 104, č. 2 (2025), s. e41128
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39792720 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135105 $b ABA008
- 999 __
- $a ok $b bmc $g 2311567 $s 1247365
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 104 $c 2 $d e41128 $e 20250110 $i 1536-5964 $m Medicine $n Medicine (Baltimore) $x MED00012436
- LZP __
- $a Pubmed-20250415